A detailed history of 9258 Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, 9258 Wealth Management, LLC holds 979 shares of AMGN stock, worth $309,364. This represents 0.05% of its overall portfolio holdings.

Number of Shares
979
Previous 978 0.1%
Holding current value
$309,364
Previous $278,000 9.71%
% of portfolio
0.05%
Previous 0.04%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 02, 2024

BUY
$262.75 - $319.31 $262 - $319
1 Added 0.1%
979 $305,000
Q1 2024

May 03, 2024

SELL
$268.87 - $324.56 $50,278 - $60,692
-187 Reduced 16.05%
978 $278,000
Q4 2023

Feb 06, 2024

BUY
$255.7 - $288.46 $3,068 - $3,461
12 Added 1.04%
1,165 $335,000
Q3 2023

Nov 08, 2023

SELL
$218.65 - $271.46 $437 - $542
-2 Reduced 0.17%
1,153 $309,000
Q2 2023

Aug 08, 2023

BUY
$214.27 - $253.37 $7,499 - $8,867
35 Added 3.13%
1,155 $256,000
Q1 2023

May 03, 2023

BUY
$225.79 - $275.2 $64,801 - $78,982
287 Added 34.45%
1,120 $270,000
Q4 2022

Feb 03, 2023

BUY
$229.03 - $291.01 $190,781 - $242,411
833 New
833 $218,000
Q2 2022

Aug 04, 2022

BUY
$230.71 - $256.74 $28,608 - $31,835
124 Added 13.43%
1,047 $255,000
Q1 2022

May 13, 2022

SELL
$219.27 - $242.57 $3,508 - $3,881
-16 Reduced 1.7%
923 $223,000
Q4 2021

Feb 11, 2022

BUY
$198.88 - $227.6 $186,748 - $213,716
939 New
939 $211,000
Q2 2021

Aug 13, 2021

SELL
$233.58 - $259.14 $205,783 - $228,302
-881 Closed
0 $0
Q1 2021

May 11, 2021

SELL
$221.91 - $258.6 $8,654 - $10,085
-39 Reduced 4.24%
881 $219,000
Q4 2020

Feb 10, 2021

SELL
$216.38 - $257.67 $1,081 - $1,288
-5 Reduced 0.54%
920 $212,000
Q3 2020

Nov 13, 2020

BUY
$234.65 - $260.95 $217,051 - $241,378
925 New
925 $201,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track 9258 Wealth Management, LLC Portfolio

Follow 9258 Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of 9258 Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on 9258 Wealth Management, LLC with notifications on news.